The modulation of solubilized type 1 and type 2 benzodiazepine receptors from cow brain by yaminobutyric acid (GABA), divalent cations, and anions has been evaluated. 
The ionic modulation of neurotransmitter receptorbinding sites in some instances may relate to the synaptic actions of the transmitters. Anionic effects on strychnine binding associated with glycine receptors (Young and Snyder, 1974; Muller and Snyder, 1978) correlate with the ability of the ions to reverse inhibitory postsynaptic potentials, suggesting a linkage of the glycine receptorbinding sites to chloride ion channels. Anionic modulation of y-aminobutyric acid (GABA) receptors has also been described (Enna and Snyder, 1977) . Similarly, divalent cations also enhance agonist binding to a number of receptors-for example, biogenic amine and opiate receptors (Bird and Maguire, 1978; Williams et al., 1978; Snyder and Goodman, 1980) . Benzodiazepine receptors are also influenced by ions. Anions stimulate benzodiazepine receptor binding to brain membranes (Martin and Candy, 1978, Costa et al., 1979) . Their relative potencies in enhancing benzodiazepine receptor binding parallel somewhat their ability to ' penetrate activated synaptic chloride ion channels in motor neurons (Costa et al., 1979) . Anions are also required for the barbiturate enhancement of benzodiazepine binding (Leeb-Lundberg et al., 1980; Asno and Ogasawara, 1981) . In one initial report, benzodiazepine binding was also stimulated by some divalent cations (Mackerer and Kochman, 1978) . Pharmacologic data have suggested the existence of at least two subtypes of benzodiazepine receptor which vary in their distribution in different brain regions (Squires et al., 1978; Klepner et al., 1979; Nielsen and Braestrup, 1980; Sieghart and Karobath, 1980; Ehlert et al., 1981) . We have obtained direct evidence for two benzodiazepine receptor subtypes based on differential solubilization from brain membranes (Lo et al., 1982a) . The drug specificity and regional distribution of these two types correspond to the type 1 and type 2 receptor subtypes suggested by pharmacologic data. More recently, we have shown by light microscopic autoradiography that the differential distribution of detergent-insensitive and -sensitive receptors corresponds closely to the respective variations in distribution of type 1 and type 2 receptors defined on pharmacologic grounds (Lo et al., 1983) .
In a preliminary report we showed that solubilized type 2 benzodiazepine receptors are stimulated by chloride and calcium, whereas type 1 sites are unaffected (Lo The Journal of Neuroscience Two Benzodiazepine Receptors 2271 Receptors et al., 1982b . In the present study we have explored in detail the differential modulation by anions and divalent cations of solubilized type 1 and type 2 benzodiazepine receptors and their interaction with the modulation by GABA.
Materials and Methods
["HlFlunitrazepam (["HIFNZ) was obtained from New England Nuclear. Benzodiazepines were gifts from W. Scott (Hoffmann-La Roche). All other chemicals were from commercial sources. Fresh cow brains were obtained locally and were used immediately or frozen and stored at -70°C. Solubilization of type 1 and type 2 benzodiazepine receptors. Cow brain was homogenized at 0°C in 10 vol of 50 mM phosphate buffer (KH,PO,), pH 7, 10 mM Na EDTA, 0.1 mM phenylmethylsulfonyl fluoride containing 50 pg of bacitracin, 5 yg of soybean trypsin inhibitor, and 5 pg of leupeptin/ml, and centrifuged at 50,000 x g for 15 min. Pellets were extracted twice in 2 vol of the homogenizing buffer containing 2% sodium cholate for 40 min at 4°C and centrifuged at 150,000 x g for 1 hr. Supernatants for both extractions were pooled. A buffy soft pellet was removed by resuspension in 20 vol of homogenizing buffer and centrifugation at 50,000 x g for 10 min. The insoluble hard pellet was extracted in 2 vol of homogenizing buffer containing 2% sodium cholate plus 1 M NaCl for 40 min at 4°C and centrifuged at 150,000 x g for 30 min. Detergent-soluble (type 2) and detergent plus salt-soluble (type 1) extracts were dialyzed against 2 X 8 liters of H,O for 2 hr and 15 hr in 25 mM phosphate buffer (pH 7), 0.01% sodium cholate at 4°C.
Receptor assay. The binding of ["HIFNZ was measured using the polyethylene glycolly-globulin precipitation method (Gavish et al., 1979; Gavish and Snyder, 1981) . Soluble receptor fractions extracted from 50 to 100 mg/ ml of original tissue were incubated with 0.8 nM ["HI FNZ at 0°C for 1 hr in a volume of 0.5 ml and precipitated by the addition of 0.1 ml of y-globulin (10 mg/ml) and 0.2 ml of polyethylene glycol (30% w/v), followed by washing with 3 x 3 ml of 8.5% polyethylene glycol over Whatman GF/B filters. Nonspecific binding was determined in the presence of 1 pM FNZ. Total and nonspecifically bound radioactivities were typically 3000 and 200 cpm, respectively. Ion concentration of up to 0.25 M NaCl did not affect nonspecific binding.
An alternative assay to quantify receptors uses concanavalin A-Sepharose (Lo et al., 1982a) . In this assay, receptor extracts (without dialysis) were allowed to react with concanavalin A-Sepharose (1 ml of extract/l0 mg of concanavalin A/ml of packed resin) for 2 to 3 hr or overnight at 4°C. The resin was washed with 100 to 200 vol of 25 mM phosphate buffer (pH 7.0), 0.01% sodium cholate and resuspended to 5 vol of the original extract. Aliquots of the receptor-Sepharose suspension were incubated with ["HIFNZ at 0°C for 1 hr and filtered over Whatman GF/B filters followed by three washes with 3 ml of 25 mM phosphate buffer (pH 7).
Results
Receptor solubilization and receptor-binding assay. We have shown previously that extraction of crude brain membranes with various detergents solubilizes type 2 benzodiazepine receptor sites, whereas type 1 sites resist detergent solubilization (Lo et al., 1982a) . The insoluble receptor sites can be recovered in solution by extraction with 1 M NaCl plus detergent. In order to remove endogenous GABA, high detergent, and salt concentrations which would otherwise interfere with receptor-binding activity, soluble receptor extracts were extensively dialyzed against deionized water, then against phosphate buffer containing 0.01% sodium cholate. Typically, some precipitates are noticeable after storage for 6 hr and especially in the high salt plus detergent extracts. However, receptor-binding activity remains in solution as determined by centrifugation at 150,000 x g for 1 hr. Since the particulate material did not interfere with the polyethylene glycol precipitation assay, soluble type 1 and type 2 receptor extracts were not further processed. The electrical conductance of type 1 and type 2 receptor extracts after dialysis are routinely measured to ensure similar ionic conditions for the receptor extracts and to check for the complete removal of salt. In some experiments, 1 M NaCl was added to detergent (type 2 receptor) extracts and dialyzed with the salt plus detergent extracts. In these cases, the modulation by GABA and differential ionic effects on type 2 receptors were unaffected. Hence, dialysis of the receptor extracts is able to reduce salt concentrations which would otherwise inhibit anion modulation of type 2 receptors.
Anion modulation of soluble type 1 and type 2 benzodiazepine receptors. Chloride ions enhance ["HIFNZ binding to type 2 but not type 1 soluble benzodiazepine receptors when assayed either with the precipitation method or by immobilization onto concanavalin A-Sepharose ( Fig. 1 and Table I ). The enhancement of binding by 0.1 M chloride of about 50% to soluble type 2 receptors resembles what we previously reported for a crude preparation of Triton X-lOO-solubilized benzodiazepine receptors (Gavish and Snyder, 1981) as well as results with washed membrane preparations ( Table II) . The same extent of enhancement occurs with sodium or ammonium salts of chloride (Table I) or with potassium or lithium salts (data not shown). By contrast, no stimulation of ["HIFNZ binding to solubilized type 1 receptors is observed at any concentration of chloride (Table  I and Fig. 1 ).
The relative influence of different ions on glycine (Young and Snyder, 1974) and benzodiazepine (Costa et al., 1979) binding in membranes has suggested a similarity of the anion recognition site to the chloride channel. To evaluate such a relationship with solubilized benzodiazepine receptors, we evaluated a series of 14 anions and their sodium or ammonium salts (Table I) . None of the anions stimulate ["H]FNZ binding to type 1 receptors. By contrast, chloride and bromide augment binding to type 2 receptors by about 50%, whereas iodide has a lesser effect. No other anions examined increased type 2 receptor binding. The anion specificity of soluble type 2 receptors observed in this study clearly does not agree with the specificity for enhancement of benzodiazepine binding (Costa et al., 1979) or barbiturate interactions (Leeb-Lundberg et al., 1980; Asno and Ogasawara, 1981) in membrane fragments.
Interestingly, some anions reduce binding. For example, maleate lowers binding by 30 to 50% of both of type Vol. 3, No. 11, Nov. 1983 (0) in the presence of NaCl, NaBr, and NaI did not differ from control values. The experiment was replicated four times with variations less than 10%. This finding is in agreement with above results on solubilized type 2 receptors.
Modulation of soluble benzodiazepine receptors by divalent cations. In an initial report Mackerer and Kochman (1978) found that some divalent cations could enhance benzodiazepine binding in rat brain membranes, although the membranes were not treated with chelating agents to remove endogenous divalent cations. We prepared and solubilized membranes with EDTA to remove endogenous divalent cations and GABA prior to solubilization followed by extensive dialysis to remove the chelating agent. Under these conditions substantial stimulation of [3H]FNZ binding by divalent cations to type 2 solubilized receptors is observed (Fig. 4 and Table IV) . Some enhanced binding is detected with as little as 0.2 mM calcium chloride with maximal effects at 5 InM. The stimulation by calcium is blocked entirely by treatment with equimolar amounts of EGTA. In marked contrast, no augmentation of ["H]FNZ binding to type 1 solubilized receptors occurs with any divalent cations tested.
Unlike the effect of chloride, the stimulation of [3H] FNZ binding to type 2 receptors by calcium involves an increased number of binding sites with no effect on KD (Fig. 4) . These results differ from those of Mackerer and Kochman (1978) who, using intact membranes, reported that nickel increased benzodiazepine affinity rather than numbers of sites.
The stimulation of type 2 receptor binding by calcium is apparent with a variety of divalent cations (Table IV) . Maximal enhancement to about 220 to 260% of control levels is similar for most of the divalent cations. Copper and nickel are the most potent divalent cations, producing half-maximal stimulation at about 0.2 mM, about 5 times more potent than calcium.
Interactions between GABA, divalent cation, and anion in modulation of solubilized type 2 benzodiazepine receptor. To ascertain whether GABA, anions, and divalent cations influence type 2 benzodiazepine receptor binding at similar or disparate sites, we evaluated interactions between them (Figs. 5 and 6 ). In the presence of chloride, calcium is still able to stimulate ["HIFNZ binding (Fig.  5) . The ability of calcium to augment chloride enhancement diminishes with increasing concentration of calcium. In other words, the dose response of calcium enhancement in type 2 receptor binding appears to be shallower in the presence than in the absence of chloride ions. Furthermore, calcium enhances [3H]FNZ binding by increasing the B,,,, whereas chloride stimulation involves an increase both in affinity and B,,,. This indicates that anions and divalent cations do not exert their actions through the same mechanism or a similar site. However, anions and divalent cations interact in a complex manner in modulating type 2 receptors.
GABA modulation of benzodiazepine receptors differs markedly from that of chloride and divalent cations in that GABA stimulates ["HIFNZ binding to type 1 receptors with the same potency and to the same extent as is observed with type 2 receptors (Fig. 3) . This observation also confirms our earlier study of solubilized type 1 and type 2 receptors in which we showed that GABA in- Receptor binding was assayed at 0°C as described in the legend to Figure 1 . The experiment was replicated twice with variations less than 20%. calcium and GABA must exert their actions through different mechanisms via separate sites. Calcium enhancement is additive to GABA stimulation (Fig. 5) . Furthermore, GABA enhancement appears to be augmented by calcium and increases with increasing concentration of calcium. The interaction between GABA and calcium is distinctly different from the interaction between chloride and calcium (Fig. 5) .
In the presence of either 0.1 M or 0.025 M chloride, GABA still increases type 2 receptor binding indicating additivity of chloride and GABA effects. The potency of GABA in stimulating receptor binding is increased 5-fold in the presence of chloride, with half-maximal stimulation (ECo) values for GABA of 1.5 PM and 0.3 PM in the absence and presence of 0.1 M chloride, respectively. These EC. values were calculated by log-probit analysis using six to eight GABA concentrations with ECsO values varying less than 20% in three independent determinations. Unlike chloride, calcium does not change the potency of GABA in stimulating type 2 receptor binding. This binding supports separate mechanisms for chloride and calcium stimulation.
Effects of agents influencing oxidation-reduction on modulation of solubilized benzodiazepine receptors by GABA and ions. Some divalent cations influence many oxidative-reductive reactions, especially those involving sulfhydryl groups. To ascertain whether such actions might play a role in the influence of ions on solubilized benzodiazepine receptors, we explored the effects of /3-mercaptoethanol, dithionitrobenzoic acid (DTNB), and ascorbic acid on the ability of GABA, chloride, and divalent cations to regulate solubilized benzodiazepine receptors ( Table V) . All of the stimulatory effects of GABA, chloride, and calcium are similar in the presence or absence of P-mercaptoethanol, DTNB, and ascorbic acid in the concentrations used in this study. The failure of P-mercaptoethanol and DTNB to alter the actions of divalent cations, chloride, or GABA suggests that oxidation-reduction effects in sulfhydryl groups of benzodiazepine receptors are not crucial. Similarly, the oxidative state of the receptor appears to be unimportant for its modulation by GABA and ions, since enhancement of the receptor activity is not affected by the addition of ascorbic acid.
Differential protection of soluble benzodiazepine receptor binding from heat inactivation of divalent cations, chloride, and GABA. GABA, chloride, phosphate, and calcium ions have been shown to protect benzodiazepine receptor binding in intact brain membranes from heat inactivation (Squires et al., 1978; Gavish and Snyder, 1980; Squires, 1981; Squires and Saederup, 1982) . To ascertain whether these agents augment ["HIFNZ binding by solubilized type 1 and type 2 receptors at the same sites as those that mediate protection from heat inactivation, we conducted heat inactivation experiments (Fig.  7) . GABA clearly protects both type 1 and type 2 soluble receptors from heat inactivation, which fits with its ability to enhance binding of both receptors. In contrast, calcium and chloride protect type 2 but not type 1 receptors from heat inactivation, which goes along with their ability to stimulate binding of soluble type 2 but not type 1 receptors. These findings further support the notion that type 2 but not type 1 receptors possess specific recognition sites for divalent cations and chloride whereas both receptors have recognition sites for GABA. The results also indicate that GABA recognition sites on both subtypes of benzodiazepine receptors and the divalent cation and chloride sites on type 2 receptors probably exist in fairly close proximity to the benzodiazepine recognition site in the soluble state.
Discussion
In the present study we have evaluated two physically separated solubilized benzodiazepine receptors designated type 1 and type 2. Earlier we showed that treating brain membranes with Triton X-100 solubilizes only a fixed and limited proportion of benzodiazepine-binding sites despite repeated treatment with high concentrations of Triton X-100, whereas the residual receptor binding can be completely solubilized by a combination of Triton X-100 and 1 M NaCl (Lo et al., 1982a) . The Vol. 3, No. 11, Nov. 1983 receptors solubilized by Triton X-100 alone are more highly concentrated in the hippocampus and corpus striatum than in the cerebellum, whereas receptors solubilized only with salt plus Triton X-100 are more highly concentrated in the cerebellum. The triazolopyridazine, CL218872, and P-carboline esters, which are thought to be selective for type I receptors, have greater potency at the sites that require salt plus Triton X-100 to solubilize them than at those receptors readily solubilized with Triton X-100. Accordingly, we designated the sites solubilized with Triton X-100 alone as type 2 receptors and those that require Triton X-100 plus NaCl for solubilization as type 1 receptors.
This distinction has been supported by our recent autoradiographic studies (Lo et al., 1983) . Using differential displacement by CL218872, Young et al. (1981) observed different microscopic distributions of pharmacologially defined type 1 and type 2 receptors. We have compared the autoradiographic localization of benzodiazepine receptors before and after treatment with detergents (Lo et al., 1983) . The distribution of detergent-resistant receptors corresponds closely to that of pharmacologically defined type 1 benzodiazepine receptors, further supporting the notion that type 1 receptors are those less readily solubilized by detergent.
The major finding of the present study is the differential regulation of solubilized type 1 and type 2 receptors by various ions. In the membrane-bound state benzodiazepine receptor binding is enhanced by a variety of anions with relative activities that parallel somewhat their effects in reversing inhibitory postsynaptic potentials in spinal cord and hippocampus, perhaps reflecting an association with chloride synaptic channels (Costa et al., 1979) . Although the ratio of type 1 and type 2 receptors varies in different brain regions, all regions evaluated thus far possess both subtypes of receptors so that, using intact membrane preparation, it is difficult to ascertain rigorously whether anion effects involve predominantly one or the other receptor subtype. By differential detergent extraction we can physically separate type 1 and type 2 receptors and have observed that chloride stimulation of binding in the absence of GABA and divalent cations occurs only with type 2 receptors. Anion specificity is somewhat different from specificity in the membrane-bound state, since it is apparent only with chloride and bromide and to some extent with iodide. This indicates that the site for anion modulation in type 2 receptors is not the putative chloride channel suggested by Costa et al. (1979) . However, we cannot rule out the possibility that anions, in addition to modulating the benzodiazepine receptor, could interact with the GABA receptor and the barbiturate-binding site or with the putative chloride channel in its lipid environment in the membrane state.
In order to deduce whether chloride stimulation in membrane-bound benzodiazepine receptor is exclusively at type 2 receptor sites, we have used a concentration of CL218827 to displace ['H]FNZ binding to type 1 receptor sites in washed native hippocampal membranes. In this manner, we show that chloride stimulation in native membranes is attributed to type 2 and not type 1 receptor sites. The mechanism of anion-induced affinity increase 2278 Lo and Snyder Vol. 3, No. 11, Nov. 1983 in type 2 receptor is difficult to explain in physical terms; it is possible that anions (like GABA) exert their actions through an anion recognition site on or near the benzodiazepine-binding site. Increases in receptor B,,, caused by anions could be due to augmentation of trace amounts of cations present in the experiments. Such increases in the number of receptor sites could be accounted for by ion-induced conversion of low affinity sites not detectable by present binding techniques to high affinity states. In the membrane state anions have been reported to increase both the receptor affinity (Costa et al., 1979) and B,,, (Squires et al., 1978) . We find that anions increase type 2 receptor binding by a combination of increase in affinity and B,,,.
The significance of the divalent cation effect on solubilized type 2 receptors is unclear. For numerous receptors, agonist-binding activity is enhanced by divalent cations, which is thought to involve interactions with GTP-binding sites (Bird and Maguire, 1978; Williams et al., 1978; Rodbell, 1980) . For some of these receptors the divalent cations vary in potency, with manganese often being most active. The similar potency of many divalent cations at type 2 receptors may indicate a different type of action, especially as no effect of guanine nucleotides on benzodiazepine receptors has yet been described or detected in our laboratory (M. M. S. Lo and S. H. Snyder, unpublished observations).
Thus the physiologic rule of the anion and divalent cation effects on type 2 receptors is unclear. The fact that these effects occur at physiologic concentrations of chloride and calcium suggests that they may be involved in the pharmacologic actions of benzodiazepines. If so, then these ionic influences would be relevant to actions mediated via type 2 and not type 1 receptors. This selectivity may provide a valuable probe for discriminating the different roles of the two receptor subtypes.
